Clinical trial
Investigating the Use of Quercetin on Glucose Absorption in Obesity, and Obesity…
NCT00065676 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00065676 |
|---|---|
| Title | Investigating the Use of Quercetin on Glucose Absorption in Obesity, and Obesity With Type 2 Diabetes |
| Official title | Inhibition of Intestinal Glucose Absorption by the Bioflavonoid Quercetin in the Obese and in Obese Type 2 Diabetics |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Obesity, Diabetes |
| Intervention type | Other |
| Interventions | Quercetin, Placebo |
| Enrollment | 24 |
| Start date | Apr 30, 2010 |
| Primary completion | Dec 21, 2015 |
| Completion | Aug 6, 2021 |
| First posted | Jul 31, 2003 |
| Last update posted | Feb 5, 2026 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: